Quarterly Strategy Report: Has Innovation Bottomed?

It appears to us that global innovation has bottomed and offers attractive value. An extended analysis follows in our Quarterly Strategy Report: Has Innovation Bottomed?

Prefer to download this presentation in PDF? Please click here.

1. Summary

-Innovation as a factor appears have bottomed earlier in 2022. Looking at the quintile spread for the R&D sales factor reveals the factor underperformance has ended for the major developed regions of the world.

-The Bloomberg R&D Leaders Index is a great proxy for the most innovative companies in the US. It has experienced a record valuation drawdown relative to the S&P 500 Index, but that drawdown ended in May. Given the magnitude of actual and projected rate hikes we’ve experienced since then, it is amazing this long duration group of stocks has held the line. Perhaps they have fully discounted the rate hiking cycle and/or economic and profits recession potentially ahead.

-The Bloomberg R&D Leaders Index has seen its EPS grow by 12.58% over the last 15 years, while the S&P 500 grew EPS at a 6.82% compound rate. The Bloomberg R&D Leaders sells for 21.58x forward EPS while the S&P 500 sells for 17.15x forward EPS. This means the Bloomberg R&D Index P/E-to-Growth Rate is 1.72x while it is 2.51x for the S&P 500. This means on a P/E-to-growth valuation basis, the Bloomberg R&D Leaders Index sells for a 31% discount.

-Our Knowledge Leaders baskets have exhibited similar lows this year. Our Asia basket bottomed compared to the S&P 500 in April; our Knowledge Leaders North America made a relative low in May; our Knowledge Leaders Europe basket made a relative low in June.

-It appears to us that global innovation has bottomed and offers attractive value.​​​​​​